Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,290 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 823
Recruiting: 455
Ph III recruiting: 55
Growth YoY: −4.1%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 301–309 of 309 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00712595	Mifepristone for Treatment of Uterine Fibroids(Mifemyo)	completed	Phase 2 / Phase 3	200	Mediterranea Medica S. L.OTHER	1	Apr 23, 2009	clinicaltrials
NCT00532818	Hydralazine Valproate for Cervical Cancer	unknown	Phase 3	143	National Institute of CancerologíaOTHER_GOV	1	Mar 30, 2009	clinicaltrials